Ex Vivo COL7A1 Correction for Recessive Dystrophic Epidermolysis Bullosa Using CRISPR/Cas9 and Homology-Directed Repair
2018 · Molecular Therapy — Nucleic Acids · 67 citations
https://doi.org/10.1016/j.omtn.2018.06.008
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
38
Papers
480
Citations
12
h-index
13
i10-index
Araksya Izmiryan is an academic researcher. The author has contributed to research in topics: Skin and Cellular Biology Research & RNA regulation and disease & CRISPR and Genetic Engineering. The author has an h-index of 12, co-authored 33 publications.
ORCID: 0000-0002-6358-6980https://doi.org/10.1016/j.omtn.2018.06.008
https://doi.org/10.1016/j.jid.2024.10.246
Click to start Chat